The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.

Szer, Jeff; Weisdorf, Daniel; Querol, Sergio; Foeken, Lydia; Madrigal, Alejandro

Szer, Jeff; Weisdorf, Daniel; Querol, Sergio; Foeken, Lydia; Madrigal, Alejandro.

Szer J; Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia. Jeff.Szer@mh.org.au.
Weisdorf D; Blood and Marrow Transplant Program and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Querol S; Frederic Duran i Jordà Center, Catalan Blood and Tissue Bank (BST), Barcelona, Spain.
Foeken L; World Marrow Donor Association, Schipholweg 57, 2316 ZL, Leiden, The Netherlands.
Madrigal A; Anthony Nolan Research Institute Royal Free Hospital & UCL Medical School, London, UK.

Bone Marrow Transplant ; 55(10): 2043-2044, 2020 10.

Article in English | MEDLINE | ID: covidwho-808104

Subject(s)

Coronavirus Infections/epidemiology; Hematopoietic Stem Cell Transplantation/statistics & numerical data; Hematopoietic Stem Cells; Pneumonia, Viral/epidemiology; Betacoronavirus; COVID-19; Coronavirus Infections/prevention & control; Databases, Factual; Humans; International Cooperation; Pandemics/prevention & control; Patient Safety; Pneumonia, Viral/prevention & control; Registries; SARS-CoV-2; Tissue Donors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Hematopoietic Stem Cells / Coronavirus Infections / Hematopoietic Stem Cell Transplantation Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: Bone Marrow Transplant Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: S41409-020-0873-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google